Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;71(9):1545-1552.
doi: 10.1002/art.40901. Epub 2019 Aug 1.

The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study

Ali Duarte-García  1 , Michael M Pham  1 , Cynthia S Crowson  1 , Shreyasee Amin  1 , Kevin G Moder  1 , Rajiv K Pruthi  1 , Kenneth J Warrington  1 , Eric L Matteson  1
Affiliations

The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study

Ali Duarte-García et al. Arthritis Rheumatol. 2019 Sep.

Erratum in

Abstract

Objective: To estimate the annual incidence and prevalence of and frequency of mortality associated with antiphospholipid syndrome (APS).

Methods: An inception cohort of patients with incident APS in 2000-2015 from a geographically well-defined population was identified based on comprehensive individual medical records review. All cases met the 2006 Sydney criteria for APS (primary definition) or had a diagnosis of APS confirmed by physician consensus (secondary definition). Levels of lupus anticoagulant, IgM and IgG anticardiolipin antibodies, and anti-β2-glycoprotein I antibodies were tested in a centralized laboratory. Incidence rates were age- and sex-adjusted to the 2010 US white population. Prevalence estimates were obtained from the incidence rates, assuming that there was no increased mortality associated with APS and that migration in or out of the area was independent of disease status.

Results: Among this cohort in 2000-2015, 33 cases of incident APS, as defined by the Sydney criteria, were identified (mean age of patients 54.2 years; 55% female, 97% white). The annual incidence of APS in adults ages ≥18 years was 2.1 (95% confidence interval [95% CI] 1.4-2.8) per 100,000 population. Incidence rates were similar in both sexes. The estimated prevalence of APS was 50 (95% CI 42-58) per 100,000 population, and was similar in both sexes. Six patients (18%) had a concurrent diagnosis of systemic lupus erythematosus. The most frequent clinical manifestation was deep vein thrombosis. The overall frequency of mortality among patients with APS was not significantly different from that in the general population (standardized mortality ratio 1.61, 95% CI 0.74-3.05).

Conclusion: APS occurred in ~2 persons per 100,000 population per year. The estimated prevalence was 50 per 100,000 population. Overall mortality was not notably different from that observed in the general population.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Flowchart describing the screening process for the identification of patients with antiphospholipid Syndrome (APS) diagnosed in Olmsted County, Minnesota from 2000-2015. aCL; anticadiolipin, anti-β2GPI; anti-β2-glycoprotein I.
Figure 2.
Figure 2.
Age- and sex- specific incidences of antiphospholipid syndrome by the Sydney criteria definition (top panel) and the expanded cohort by physician consensus (bottom panel).
See this image and copyright information in PMC

Comment in

References

    1. Corban MT, Duarte-Garcia A, McBane RD, Matteson EL, Lerman LO, Lerman A. Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics. J Am Coll Cardiol. 2017;69(18):2317–30. doi: 10.1016/j.jacc.2017.02.058. PubMed PMID: 28473138. - DOI - PubMed
    1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306. doi: 10.1111/j.1538-7836.2006.01753.x. PubMed PMID: 16420554. - DOI - PubMed
    1. Petri M Update on anti-phospholipid antibodies in SLE: the Hopkins’ Lupus Cohort. Lupus. 2010;19(4):419–23. doi: 10.1177/0961203309360541. PubMed PMID: 20353980. - DOI - PubMed
    1. Erkan D, Derksen R, Levy R, Machin S, Ortel T, Pierangeli S, et al. Antiphospholipid Syndrome Clinical Research Task Force report. Lupus. 2011;20(2):219–24. Epub 2011/02/10. doi: 10.1177/0961203310395053. PubMed PMID: 21303838. - DOI - PubMed
    1. Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, Ramire de Jesus G, Erkan D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res (Hoboken). 2013;65(11):1869–73. doi: 10.1002/acr.22066. PubMed PMID: 23861221. - DOI - PubMed

Publication types

MeSH terms